Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Cleft Alveolus Reconstruction Using a Three-Dimensional Printed Bioresorbable Scaffold With Human Bone Marrow Cells

Authors
Ahn, GeunseonLee, Jeong-SeokYun, Won-SooShim, Jin-HyungLee, Ui-Lyong
Issue Date
Oct-2018
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Keywords
Bioresorbable scaffold; cleft alveolus reconstruction; human bone marrow cells; three-dimensional printing
Citation
JOURNAL OF CRANIOFACIAL SURGERY, v.29, no.7, pp 1880 - 1883
Pages
4
Journal Title
JOURNAL OF CRANIOFACIAL SURGERY
Volume
29
Number
7
Start Page
1880
End Page
1883
URI
https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/45104
DOI
10.1097/SCS.0000000000004747
ISSN
1049-2275
1536-3732
Abstract
Bone tissue engineering technology based on scaffold has been applied for cleft lip and palate treatment. However, clinical applications of patient-specific three-dimensional (3D) scaffolds have rarely been performed. In this study, a clinical case using patient-specific 3D-printed bioresorbable scaffold with bone marrow stromal cells collected from iliac crest in the operating room has been introduced. At 6-month after transplantation, the bone volume of the newly regenerated bone was approximately 45% of the total defect volume. Bone mineral density of the newly regenerated bone was about 75% compared to the surrounding bone. The Hounsfield unit value was higher than that of cancellous maxillary alveolar bone and lower than that of the cortical maxillary alveolar bone. Bone-marrow-derived mesenchymal stem cells-seeded 3D-printed patient-specific polycaprolactone scaffolds offer a promising alternative for alveolar cleft reconstruction and other bony defects.
Files in This Item
There are no files associated with this item.
Appears in
Collections
College of Medicine > College of Medicine > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Altmetrics

Total Views & Downloads

BROWSE